Using the Johns Hopkins' Aggregated Diagnosis Groups (ADGs) to predict 1-year mortality in population-based cohorts of patients with diabetes in Ontario, Canada

Diabet. Med. 29, 11341141 (2012) Abstract Aims There are limited validated methods to ascertain comorbidities for risk adjustment in ambulatory populations of patients with diabetes using administrative health-care databases. The objective was to examine the ability of the Johns Hopkins Aggregated Diagnosis Groups to predict mortality in population-based ambulatory samples of both incident and prevalent subjects with diabetes. Methods Retrospective cohorts constructed using population-based administrative data. The incident cohort consisted of all 346 297 subjects diagnosed with diabetes between 1April 2004 and 31 March 2008. The prevalent cohort consisted of all 879 849 subjects with pre-existing diabetes on 1 January, 2007. The outcome was death within 1 year of the subjects index date. Results A logistic regression model consisting of age, sex and indicator variables for 22 of the 32 Johns Hopkins Aggregated Diagnosis Group categories had excellent discrimination for predicting mortality in incident diabetes patients: the c-statistic was 0.87 in an independent validation sample. A similar model had excellent discrimination for predicting mortality in prevalent diabetes patients: the c-statistic was 0.84 in an independent validation sample. Both models demonstrated very good calibration, denoting good agreement between observed and predicted mortality across the range of predicted mortality in which the large majority of subjects lay. For comparative purposes, regression models incorporating the Charlson comorbidity index, age and sex, age and sex, and age alone had poorer discrimination than the model that incorporated the Johns Hopkins Aggregated Diagnosis Groups. Conclusions Logistical regression models using age, sex and the John Hopkins Aggregated Diagnosis Groups were able to accurately predict 1-year mortality in population-based samples of patients with diabetes.